Global Zika Virus Vaccines Market Insights, Forecast to 2029

The global Zika Virus Vaccines market is projected to grow from US$ 13880 million in 2023 to US$ 16470 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.9% during the forecast period.

The US & Canada market for Zika Virus Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Zika Virus Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Zika Virus Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key manufacturers of Zika Virus Vaccines include NHI, Sanofi, GSK, Bharat., Takeda, Inovio Pharmaceuticals, GeneOne Life Science Inc, PaxVax and Gilead Sciences Inc., etc. In 2022, the global top five players had a share approximately % in terms of revenue.

In terms of production side, this report researches the Zika Virus Vaccines production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.

In terms of consumption side, this report focuses on the sales of Zika Virus Vaccines by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.

Report Includes:

This report presents an overview of global market for Zika Virus Vaccines, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Zika Virus Vaccines, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Zika Virus Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Zika Virus Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Zika Virus Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Zika Virus Vaccines sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including NHI, Sanofi, GSK, Bharat., Takeda, Inovio Pharmaceuticals, GeneOne Life Science Inc, PaxVax and Gilead Sciences Inc., etc.

1.1 Zika Virus Vaccines Product Introduction

1.2 Market by Type

1.2.1 Global Zika Virus Vaccines Market Size by Type, 2018 VS 2022 VS 2029

1.2.2 DNA Vaccine

1.2.3 Inactivated Vaccine

1.2.4 Purified Inactivated Vaccine

1.2.5 Table of Contents

1.3 Market by Application

1.3.1 Global Zika Virus Vaccines Market Size by Application, 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Academic and Research

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Zika Virus Vaccines Production Capacity (2018-2029)

2.2 Global Zika Virus Vaccines Production by Region: 2018 VS 2022 VS 2029

2.3 Global Zika Virus Vaccines Production by Region

2.3.1 Global Zika Virus Vaccines Historic Production by Region (2018-2023)

2.3.2 Global Zika Virus Vaccines Forecasted Production by Region (2024-2029)

2.3.3 Global Zika Virus Vaccines Production Market Share by Region (2018-2029)

2.4 North America

2.5 Europe

2.6 China

2.7 Japan

3.1 Global Zika Virus Vaccines Revenue Estimates and Forecasts 2018-2029

3.2 Global Zika Virus Vaccines Revenue by Region

3.2.1 Global Zika Virus Vaccines Revenue by Region: 2018 VS 2022 VS 2029

3.2.2 Global Zika Virus Vaccines Revenue by Region (2018-2023)

3.2.3 Global Zika Virus Vaccines Revenue by Region (2024-2029)

3.2.4 Global Zika Virus Vaccines Revenue Market Share by Region (2018-2029)

3.3 Global Zika Virus Vaccines Sales Estimates and Forecasts 2018-2029

3.4 Global Zika Virus Vaccines Sales by Region

3.4.1 Global Zika Virus Vaccines Sales by Region: 2018 VS 2022 VS 2029

3.4.2 Global Zika Virus Vaccines Sales by Region (2018-2023)

3.4.3 Global Zika Virus Vaccines Sales by Region (2024-2029)

3.4.4 Global Zika Virus Vaccines Sales Market Share by Region (2018-2029)

3.5 US & Canada

3.6 Europe

3.7 China

3.8 Asia (excluding China)

3.9 Middle East, Africa and Latin America

4.1 Global Zika Virus Vaccines Sales by Manufacturers

4.1.1 Global Zika Virus Vaccines Sales by Manufacturers (2018-2023)

4.1.2 Global Zika Virus Vaccines Sales Market Share by Manufacturers (2018-2023)

4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Zika Virus Vaccines in 2022

4.2 Global Zika Virus Vaccines Revenue by Manufacturers

4.2.1 Global Zika Virus Vaccines Revenue by Manufacturers (2018-2023)

4.2.2 Global Zika Virus Vaccines Revenue Market Share by Manufacturers (2018-2023)

4.2.3 Global Top 10 and Top 5 Companies by Zika Virus Vaccines Revenue in 2022

4.3 Global Zika Virus Vaccines Sales Price by Manufacturers

4.4 Global Key Players of Zika Virus Vaccines, Industry Ranking, 2021 VS 2022 VS 2023

4.5 Analysis of Competitive Landscape

4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

4.5.2 Global Zika Virus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.6 Global Key Manufacturers of Zika Virus Vaccines, Manufacturing Base Distribution and Headquarters

4.7 Global Key Manufacturers of Zika Virus Vaccines, Product Offered and Application

4.8 Global Key Manufacturers of Zika Virus Vaccines, Date of Enter into This Industry

4.9 Mergers & Acquisitions, Expansion Plans

5.1 Global Zika Virus Vaccines Sales by Type

5.1.1 Global Zika Virus Vaccines Historical Sales by Type (2018-2023)

5.1.2 Global Zika Virus Vaccines Forecasted Sales by Type (2024-2029)

5.1.3 Global Zika Virus Vaccines Sales Market Share by Type (2018-2029)

5.2 Global Zika Virus Vaccines Revenue by Type

5.2.1 Global Zika Virus Vaccines Historical Revenue by Type (2018-2023)

5.2.2 Global Zika Virus Vaccines Forecasted Revenue by Type (2024-2029)

5.2.3 Global Zika Virus Vaccines Revenue Market Share by Type (2018-2029)

5.3 Global Zika Virus Vaccines Price by Type

5.3.1 Global Zika Virus Vaccines Price by Type (2018-2023)

5.3.2 Global Zika Virus Vaccines Price Forecast by Type (2024-2029)

6.1 Global Zika Virus Vaccines Sales by Application

6.1.1 Global Zika Virus Vaccines Historical Sales by Application (2018-2023)

6.1.2 Global Zika Virus Vaccines Forecasted Sales by Application (2024-2029)

6.1.3 Global Zika Virus Vaccines Sales Market Share by Application (2018-2029)

6.2 Global Zika Virus Vaccines Revenue by Application

6.2.1 Global Zika Virus Vaccines Historical Revenue by Application (2018-2023)

6.2.2 Global Zika Virus Vaccines Forecasted Revenue by Application (2024-2029)

6.2.3 Global Zika Virus Vaccines Revenue Market Share by Application (2018-2029)

6.3 Global Zika Virus Vaccines Price by Application

6.3.1 Global Zika Virus Vaccines Price by Application (2018-2023)

6.3.2 Global Zika Virus Vaccines Price Forecast by Application (2024-2029)

7.1 US & Canada Zika Virus Vaccines Market Size by Type

7.1.1 US & Canada Zika Virus Vaccines Sales by Type (2018-2029)

7.1.2 US & Canada Zika Virus Vaccines Revenue by Type (2018-2029)

7.2 US & Canada Zika Virus Vaccines Market Size by Application

7.2.1 US & Canada Zika Virus Vaccines Sales by Application (2018-2029)

7.2.2 US & Canada Zika Virus Vaccines Revenue by Application (2018-2029)

7.3 US & Canada Zika Virus Vaccines Sales by Country

7.3.1 US & Canada Zika Virus Vaccines Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 US & Canada Zika Virus Vaccines Sales by Country (2018-2029)

7.3.3 US & Canada Zika Virus Vaccines Revenue by Country (2018-2029)

7.3.4 U.S.

7.3.5 Canada

8.1 Europe Zika Virus Vaccines Market Size by Type

8.1.1 Europe Zika Virus Vaccines Sales by Type (2018-2029)

8.1.2 Europe Zika Virus Vaccines Revenue by Type (2018-2029)

8.2 Europe Zika Virus Vaccines Market Size by Application

8.2.1 Europe Zika Virus Vaccines Sales by Application (2018-2029)

8.2.2 Europe Zika Virus Vaccines Revenue by Application (2018-2029)

8.3 Europe Zika Virus Vaccines Sales by Country

8.3.1 Europe Zika Virus Vaccines Revenue by Country: 2018 VS 2022 VS 2029

8.3.2 Europe Zika Virus Vaccines Sales by Country (2018-2029)

8.3.3 Europe Zika Virus Vaccines Revenue by Country (2018-2029)

8.3.4 Germany

8.3.5 France

8.3.6 U.K.

8.3.7 Italy

8.3.8 Russia

9.1 China Zika Virus Vaccines Market Size by Type

9.1.1 China Zika Virus Vaccines Sales by Type (2018-2029)

9.1.2 China Zika Virus Vaccines Revenue by Type (2018-2029)

9.2 China Zika Virus Vaccines Market Size by Application

9.2.1 China Zika Virus Vaccines Sales by Application (2018-2029)

9.2.2 China Zika Virus Vaccines Revenue by Application (2018-2029)

10.1 Asia Zika Virus Vaccines Market Size by Type

10.1.1 Asia Zika Virus Vaccines Sales by Type (2018-2029)

10.1.2 Asia Zika Virus Vaccines Revenue by Type (2018-2029)

10.2 Asia Zika Virus Vaccines Market Size by Application

10.2.1 Asia Zika Virus Vaccines Sales by Application (2018-2029)

10.2.2 Asia Zika Virus Vaccines Revenue by Application (2018-2029)

10.3 Asia Zika Virus Vaccines Sales by Region

10.3.1 Asia Zika Virus Vaccines Revenue by Region: 2018 VS 2022 VS 2029

10.3.2 Asia Zika Virus Vaccines Revenue by Region (2018-2029)

10.3.3 Asia Zika Virus Vaccines Sales by Region (2018-2029)

10.3.4 Japan

10.3.5 South Korea

10.3.6 China Taiwan

10.3.7 Southeast Asia

10.3.8 India

11.1 Middle East, Africa and Latin America Zika Virus Vaccines Market Size by Type

11.1.1 Middle East, Africa and Latin America Zika Virus Vaccines Sales by Type (2018-2029)

11.1.2 Middle East, Africa and Latin America Zika Virus Vaccines Revenue by Type (2018-2029)

11.2 Middle East, Africa and Latin America Zika Virus Vaccines Market Size by Application

11.2.1 Middle East, Africa and Latin America Zika Virus Vaccines Sales by Application (2018-2029)

11.2.2 Middle East, Africa and Latin America Zika Virus Vaccines Revenue by Application (2018-2029)

11.3 Middle East, Africa and Latin America Zika Virus Vaccines Sales by Country

11.3.1 Middle East, Africa and Latin America Zika Virus Vaccines Revenue by Country: 2018 VS 2022 VS 2029

11.3.2 Middle East, Africa and Latin America Zika Virus Vaccines Revenue by Country (2018-2029)

11.3.3 Middle East, Africa and Latin America Zika Virus Vaccines Sales by Country (2018-2029)

11.3.4 Brazil

11.3.5 Mexico

11.3.6 Turkey

11.3.7 Israel

11.3.8 GCC Countries

12.1 NHI

12.1.1 NHI Company Information

12.1.2 NHI Overview

12.1.3 NHI Zika Virus Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

12.1.4 NHI Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

12.1.5 NHI Recent Developments

12.2 Sanofi

12.2.1 Sanofi Company Information

12.2.2 Sanofi Overview

12.2.3 Sanofi Zika Virus Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

12.2.4 Sanofi Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

12.2.5 Sanofi Recent Developments

12.3 GSK

12.3.1 GSK Company Information

12.3.2 GSK Overview

12.3.3 GSK Zika Virus Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

12.3.4 GSK Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

12.3.5 GSK Recent Developments

12.4 Bharat.

12.4.1 Bharat. Company Information

12.4.2 Bharat. Overview

12.4.3 Bharat. Zika Virus Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

12.4.4 Bharat. Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

12.4.5 Bharat. Recent Developments

12.5 Takeda

12.5.1 Takeda Company Information

12.5.2 Takeda Overview

12.5.3 Takeda Zika Virus Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

12.5.4 Takeda Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

12.5.5 Takeda Recent Developments

12.6 Inovio Pharmaceuticals

12.6.1 Inovio Pharmaceuticals Company Information

12.6.2 Inovio Pharmaceuticals Overview

12.6.3 Inovio Pharmaceuticals Zika Virus Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

12.6.4 Inovio Pharmaceuticals Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

12.6.5 Inovio Pharmaceuticals Recent Developments

12.7 GeneOne Life Science Inc

12.7.1 GeneOne Life Science Inc Company Information

12.7.2 GeneOne Life Science Inc Overview

12.7.3 GeneOne Life Science Inc Zika Virus Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

12.7.4 GeneOne Life Science Inc Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

12.7.5 GeneOne Life Science Inc Recent Developments

12.8 PaxVax

12.8.1 PaxVax Company Information

12.8.2 PaxVax Overview

12.8.3 PaxVax Zika Virus Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

12.8.4 PaxVax Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

12.8.5 PaxVax Recent Developments

12.9 Gilead Sciences Inc.

12.9.1 Gilead Sciences Inc. Company Information

12.9.2 Gilead Sciences Inc. Overview

12.9.3 Gilead Sciences Inc. Zika Virus Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

12.9.4 Gilead Sciences Inc. Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

12.9.5 Gilead Sciences Inc. Recent Developments

12.10 Intrexon Corp.

12.10.1 Intrexon Corp. Company Information

12.10.2 Intrexon Corp. Overview

12.10.3 Intrexon Corp. Zika Virus Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

12.10.4 Intrexon Corp. Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

12.10.5 Intrexon Corp. Recent Developments

12.11 NewLink Genetics Corp

12.11.1 NewLink Genetics Corp Company Information

12.11.2 NewLink Genetics Corp Overview

12.11.3 NewLink Genetics Corp Zika Virus Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

12.11.4 NewLink Genetics Corp Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

12.11.5 NewLink Genetics Corp Recent Developments

13.1 Zika Virus Vaccines Industry Chain Analysis

13.2 Zika Virus Vaccines Key Raw Materials

13.2.1 Key Raw Materials

13.2.2 Raw Materials Key Suppliers

13.3 Zika Virus Vaccines Production Mode & Process

13.4 Zika Virus Vaccines Sales and Marketing

13.4.1 Zika Virus Vaccines Sales Channels

13.4.2 Zika Virus Vaccines Distributors

13.5 Zika Virus Vaccines Customers

14.1 Zika Virus Vaccines Industry Trends

14.2 Zika Virus Vaccines Market Drivers

14.3 Zika Virus Vaccines Market Challenges

14.4 Zika Virus Vaccines Market Restraints

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables

    Table 1. Global Zika Virus Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Table 2. Major Manufacturers of DNA Vaccine

    Table 3. Major Manufacturers of Inactivated Vaccine

    Table 4. Major Manufacturers of Purified Inactivated Vaccine

    Table 5. Major Manufacturers of Table of Contents

    Table 6. Global Zika Virus Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Table 7. Global Zika Virus Vaccines Production by Region: 2018 VS 2022 VS 2029 (MT)

    Table 8. Global Zika Virus Vaccines Production by Region (2018-2023) & (MT)

    Table 9. Global Zika Virus Vaccines Production by Region (2024-2029) & (MT)

    Table 10. Global Zika Virus Vaccines Production Market Share by Region (2018-2023)

    Table 11. Global Zika Virus Vaccines Production Market Share by Region (2024-2029)

    Table 12. Global Zika Virus Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 13. Global Zika Virus Vaccines Revenue by Region (2018-2023) & (US$ Million)

    Table 14. Global Zika Virus Vaccines Revenue by Region (2024-2029) & (US$ Million)

    Table 15. Global Zika Virus Vaccines Revenue Market Share by Region (2018-2023)

    Table 16. Global Zika Virus Vaccines Revenue Market Share by Region (2024-2029)

    Table 17. Global Zika Virus Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 18. Global Zika Virus Vaccines Sales by Region (2018-2023) & (MT)

    Table 19. Global Zika Virus Vaccines Sales by Region (2024-2029) & (MT)

    Table 20. Global Zika Virus Vaccines Sales Market Share by Region (2018-2023)

    Table 21. Global Zika Virus Vaccines Sales Market Share by Region (2024-2029)

    Table 22. Global Zika Virus Vaccines Sales by Manufacturers (2018-2023) & (MT)

    Table 23. Global Zika Virus Vaccines Sales Share by Manufacturers (2018-2023)

    Table 24. Global Zika Virus Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)

    Table 25. Global Zika Virus Vaccines Revenue Share by Manufacturers (2018-2023)

    Table 26. Zika Virus Vaccines Price by Manufacturers 2018-2023 (USD/Kg)

    Table 27. Global Key Players of Zika Virus Vaccines, Industry Ranking, 2021 VS 2022 VS 2023

    Table 28. Global Zika Virus Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 29. Global Zika Virus Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zika Virus Vaccines as of 2022)

    Table 30. Global Key Manufacturers of Zika Virus Vaccines, Manufacturing Base Distribution and Headquarters

    Table 31. Global Key Manufacturers of Zika Virus Vaccines, Product Offered and Application

    Table 32. Global Key Manufacturers of Zika Virus Vaccines, Date of Enter into This Industry

    Table 33. Mergers & Acquisitions, Expansion Plans

    Table 34. Global Zika Virus Vaccines Sales by Type (2018-2023) & (MT)

    Table 35. Global Zika Virus Vaccines Sales by Type (2024-2029) & (MT)

    Table 36. Global Zika Virus Vaccines Sales Share by Type (2018-2023)

    Table 37. Global Zika Virus Vaccines Sales Share by Type (2024-2029)

    Table 38. Global Zika Virus Vaccines Revenue by Type (2018-2023) & (US$ Million)

    Table 39. Global Zika Virus Vaccines Revenue by Type (2024-2029) & (US$ Million)

    Table 40. Global Zika Virus Vaccines Revenue Share by Type (2018-2023)

    Table 41. Global Zika Virus Vaccines Revenue Share by Type (2024-2029)

    Table 42. Zika Virus Vaccines Price by Type (2018-2023) & (USD/Kg)

    Table 43. Global Zika Virus Vaccines Price Forecast by Type (2024-2029) & (USD/Kg)

    Table 44. Global Zika Virus Vaccines Sales by Application (2018-2023) & (MT)

    Table 45. Global Zika Virus Vaccines Sales by Application (2024-2029) & (MT)

    Table 46. Global Zika Virus Vaccines Sales Share by Application (2018-2023)

    Table 47. Global Zika Virus Vaccines Sales Share by Application (2024-2029)

    Table 48. Global Zika Virus Vaccines Revenue by Application (2018-2023) & (US$ Million)

    Table 49. Global Zika Virus Vaccines Revenue by Application (2024-2029) & (US$ Million)

    Table 50. Global Zika Virus Vaccines Revenue Share by Application (2018-2023)

    Table 51. Global Zika Virus Vaccines Revenue Share by Application (2024-2029)

    Table 52. Zika Virus Vaccines Price by Application (2018-2023) & (USD/Kg)

    Table 53. Global Zika Virus Vaccines Price Forecast by Application (2024-2029) & (USD/Kg)

    Table 54. US & Canada Zika Virus Vaccines Sales by Type (2018-2023) & (MT)

    Table 55. US & Canada Zika Virus Vaccines Sales by Type (2024-2029) & (MT)

    Table 56. US & Canada Zika Virus Vaccines Revenue by Type (2018-2023) & (US$ Million)

    Table 57. US & Canada Zika Virus Vaccines Revenue by Type (2024-2029) & (US$ Million)

    Table 58. US & Canada Zika Virus Vaccines Sales by Application (2018-2023) & (MT)

    Table 59. US & Canada Zika Virus Vaccines Sales by Application (2024-2029) & (MT)

    Table 60. US & Canada Zika Virus Vaccines Revenue by Application (2018-2023) & (US$ Million)

    Table 61. US & Canada Zika Virus Vaccines Revenue by Application (2024-2029) & (US$ Million)

    Table 62. US & Canada Zika Virus Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 63. US & Canada Zika Virus Vaccines Revenue by Country (2018-2023) & (US$ Million)

    Table 64. US & Canada Zika Virus Vaccines Revenue by Country (2024-2029) & (US$ Million)

    Table 65. US & Canada Zika Virus Vaccines Sales by Country (2018-2023) & (MT)

    Table 66. US & Canada Zika Virus Vaccines Sales by Country (2024-2029) & (MT)

    Table 67. Europe Zika Virus Vaccines Sales by Type (2018-2023) & (MT)

    Table 68. Europe Zika Virus Vaccines Sales by Type (2024-2029) & (MT)

    Table 69. Europe Zika Virus Vaccines Revenue by Type (2018-2023) & (US$ Million)

    Table 70. Europe Zika Virus Vaccines Revenue by Type (2024-2029) & (US$ Million)

    Table 71. Europe Zika Virus Vaccines Sales by Application (2018-2023) & (MT)

    Table 72. Europe Zika Virus Vaccines Sales by Application (2024-2029) & (MT)

    Table 73. Europe Zika Virus Vaccines Revenue by Application (2018-2023) & (US$ Million)

    Table 74. Europe Zika Virus Vaccines Revenue by Application (2024-2029) & (US$ Million)

    Table 75. Europe Zika Virus Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 76. Europe Zika Virus Vaccines Revenue by Country (2018-2023) & (US$ Million)

    Table 77. Europe Zika Virus Vaccines Revenue by Country (2024-2029) & (US$ Million)

    Table 78. Europe Zika Virus Vaccines Sales by Country (2018-2023) & (MT)

    Table 79. Europe Zika Virus Vaccines Sales by Country (2024-2029) & (MT)

    Table 80. China Zika Virus Vaccines Sales by Type (2018-2023) & (MT)

    Table 81. China Zika Virus Vaccines Sales by Type (2024-2029) & (MT)

    Table 82. China Zika Virus Vaccines Revenue by Type (2018-2023) & (US$ Million)

    Table 83. China Zika Virus Vaccines Revenue by Type (2024-2029) & (US$ Million)

    Table 84. China Zika Virus Vaccines Sales by Application (2018-2023) & (MT)

    Table 85. China Zika Virus Vaccines Sales by Application (2024-2029) & (MT)

    Table 86. China Zika Virus Vaccines Revenue by Application (2018-2023) & (US$ Million)

    Table 87. China Zika Virus Vaccines Revenue by Application (2024-2029) & (US$ Million)

    Table 88. Asia Zika Virus Vaccines Sales by Type (2018-2023) & (MT)

    Table 89. Asia Zika Virus Vaccines Sales by Type (2024-2029) & (MT)

    Table 90. Asia Zika Virus Vaccines Revenue by Type (2018-2023) & (US$ Million)

    Table 91. Asia Zika Virus Vaccines Revenue by Type (2024-2029) & (US$ Million)

    Table 92. Asia Zika Virus Vaccines Sales by Application (2018-2023) & (MT)

    Table 93. Asia Zika Virus Vaccines Sales by Application (2024-2029) & (MT)

    Table 94. Asia Zika Virus Vaccines Revenue by Application (2018-2023) & (US$ Million)

    Table 95. Asia Zika Virus Vaccines Revenue by Application (2024-2029) & (US$ Million)

    Table 96. Asia Zika Virus Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 97. Asia Zika Virus Vaccines Revenue by Region (2018-2023) & (US$ Million)

    Table 98. Asia Zika Virus Vaccines Revenue by Region (2024-2029) & (US$ Million)

    Table 99. Asia Zika Virus Vaccines Sales by Region (2018-2023) & (MT)

    Table 100. Asia Zika Virus Vaccines Sales by Region (2024-2029) & (MT)

    Table 101. Middle East, Africa and Latin America Zika Virus Vaccines Sales by Type (2018-2023) & (MT)

    Table 102. Middle East, Africa and Latin America Zika Virus Vaccines Sales by Type (2024-2029) & (MT)

    Table 103. Middle East, Africa and Latin America Zika Virus Vaccines Revenue by Type (2018-2023) & (US$ Million)

    Table 104. Middle East, Africa and Latin America Zika Virus Vaccines Revenue by Type (2024-2029) & (US$ Million)

    Table 105. Middle East, Africa and Latin America Zika Virus Vaccines Sales by Application (2018-2023) & (MT)

    Table 106. Middle East, Africa and Latin America Zika Virus Vaccines Sales by Application (2024-2029) & (MT)

    Table 107. Middle East, Africa and Latin America Zika Virus Vaccines Revenue by Application (2018-2023) & (US$ Million)

    Table 108. Middle East, Africa and Latin America Zika Virus Vaccines Revenue by Application (2024-2029) & (US$ Million)

    Table 109. Middle East, Africa and Latin America Zika Virus Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 110. Middle East, Africa and Latin America Zika Virus Vaccines Revenue by Country (2018-2023) & (US$ Million)

    Table 111. Middle East, Africa and Latin America Zika Virus Vaccines Revenue by Country (2024-2029) & (US$ Million)

    Table 112. Middle East, Africa and Latin America Zika Virus Vaccines Sales by Country (2018-2023) & (MT)

    Table 113. Middle East, Africa and Latin America Zika Virus Vaccines Sales by Country (2024-2029) & (MT)

    Table 114. NHI Company Information

    Table 115. NHI Description and Major Businesses

    Table 116. NHI Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 117. NHI Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 118. NHI Recent Development

    Table 119. Sanofi Company Information

    Table 120. Sanofi Description and Major Businesses

    Table 121. Sanofi Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 122. Sanofi Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 123. Sanofi Recent Development

    Table 124. GSK Company Information

    Table 125. GSK Description and Major Businesses

    Table 126. GSK Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 127. GSK Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 128. GSK Recent Development

    Table 129. Bharat. Company Information

    Table 130. Bharat. Description and Major Businesses

    Table 131. Bharat. Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 132. Bharat. Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 133. Bharat. Recent Development

    Table 134. Takeda Company Information

    Table 135. Takeda Description and Major Businesses

    Table 136. Takeda Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 137. Takeda Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 138. Takeda Recent Development

    Table 139. Inovio Pharmaceuticals Company Information

    Table 140. Inovio Pharmaceuticals Description and Major Businesses

    Table 141. Inovio Pharmaceuticals Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 142. Inovio Pharmaceuticals Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 143. Inovio Pharmaceuticals Recent Development

    Table 144. GeneOne Life Science Inc Company Information

    Table 145. GeneOne Life Science Inc Description and Major Businesses

    Table 146. GeneOne Life Science Inc Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 147. GeneOne Life Science Inc Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 148. GeneOne Life Science Inc Recent Development

    Table 149. PaxVax Company Information

    Table 150. PaxVax Description and Major Businesses

    Table 151. PaxVax Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 152. PaxVax Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 153. PaxVax Recent Development

    Table 154. Gilead Sciences Inc. Company Information

    Table 155. Gilead Sciences Inc. Description and Major Businesses

    Table 156. Gilead Sciences Inc. Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 157. Gilead Sciences Inc. Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 158. Gilead Sciences Inc. Recent Development

    Table 159. Intrexon Corp. Company Information

    Table 160. Intrexon Corp. Description and Major Businesses

    Table 161. Intrexon Corp. Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 162. Intrexon Corp. Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 163. Intrexon Corp. Recent Development

    Table 164. NewLink Genetics Corp Company Information

    Table 165. NewLink Genetics Corp Description and Major Businesses

    Table 166. NewLink Genetics Corp Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 167. NewLink Genetics Corp Zika Virus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 168. NewLink Genetics Corp Recent Development

    Table 169. Key Raw Materials Lists

    Table 170. Raw Materials Key Suppliers Lists

    Table 171. Zika Virus Vaccines Distributors List

    Table 172. Zika Virus Vaccines Customers List

    Table 173. Zika Virus Vaccines Market Trends

    Table 174. Zika Virus Vaccines Market Drivers

    Table 175. Zika Virus Vaccines Market Challenges

    Table 176. Zika Virus Vaccines Market Restraints

    Table 177. Research Programs/Design for This Report

    Table 178. Key Data Information from Secondary Sources

    Table 179. Key Data Information from Primary Sources

List of Figures

    Figure 1. Zika Virus Vaccines Product Picture

    Figure 2. Global Zika Virus Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 3. Global Zika Virus Vaccines Market Share by Type in 2022 & 2029

    Figure 4. DNA Vaccine Product Picture

    Figure 5. Inactivated Vaccine Product Picture

    Figure 6. Purified Inactivated Vaccine Product Picture

    Figure 7. Table of Contents Product Picture

    Figure 8. Global Zika Virus Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 9. Global Zika Virus Vaccines Market Share by Application in 2022 & 2029

    Figure 10. Hospitals

    Figure 11. Clinics

    Figure 12. Academic and Research

    Figure 13. Others

    Figure 14. Zika Virus Vaccines Report Years Considered

    Figure 15. Global Zika Virus Vaccines Capacity, Production and Utilization (2018-2029) & (MT)

    Figure 16. Global Zika Virus Vaccines Production Market Share by Region in Percentage: 2022 Versus 2029

    Figure 17. Global Zika Virus Vaccines Production Market Share by Region (2018-2029)

    Figure 18. Zika Virus Vaccines Production Growth Rate in North America (2018-2029) & (MT)

    Figure 19. Zika Virus Vaccines Production Growth Rate in Europe (2018-2029) & (MT)

    Figure 20. Zika Virus Vaccines Production Growth Rate in China (2018-2029) & (MT)

    Figure 21. Zika Virus Vaccines Production Growth Rate in Japan (2018-2029) & (MT)

    Figure 22. Global Zika Virus Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 23. Global Zika Virus Vaccines Revenue 2018-2029 (US$ Million)

    Figure 24. Global Zika Virus Vaccines Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Figure 25. Global Zika Virus Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029

    Figure 26. Global Zika Virus Vaccines Revenue Market Share by Region (2018-2029)

    Figure 27. Global Zika Virus Vaccines Sales 2018-2029 ((MT)

    Figure 28. Global Zika Virus Vaccines Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (MT)

    Figure 29. Global Zika Virus Vaccines Sales Market Share by Region (2018-2029)

    Figure 30. US & Canada Zika Virus Vaccines Sales YoY (2018-2029) & (MT)

    Figure 31. US & Canada Zika Virus Vaccines Revenue YoY (2018-2029) & (US$ Million)

    Figure 32. Europe Zika Virus Vaccines Sales YoY (2018-2029) & (MT)

    Figure 33. Europe Zika Virus Vaccines Revenue YoY (2018-2029) & (US$ Million)

    Figure 34. China Zika Virus Vaccines Sales YoY (2018-2029) & (MT)

    Figure 35. China Zika Virus Vaccines Revenue YoY (2018-2029) & (US$ Million)

    Figure 36. Asia (excluding China) Zika Virus Vaccines Sales YoY (2018-2029) & (MT)

    Figure 37. Asia (excluding China) Zika Virus Vaccines Revenue YoY (2018-2029) & (US$ Million)

    Figure 38. Middle East, Africa and Latin America Zika Virus Vaccines Sales YoY (2018-2029) & (MT)

    Figure 39. Middle East, Africa and Latin America Zika Virus Vaccines Revenue YoY (2018-2029) & (US$ Million)

    Figure 40. The Zika Virus Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

    Figure 41. The Top 5 and 10 Largest Manufacturers of Zika Virus Vaccines in the World: Market Share by Zika Virus Vaccines Revenue in 2022

    Figure 42. Global Zika Virus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

    Figure 43. Global Zika Virus Vaccines Sales Market Share by Type (2018-2029)

    Figure 44. Global Zika Virus Vaccines Revenue Market Share by Type (2018-2029)

    Figure 45. Global Zika Virus Vaccines Sales Market Share by Application (2018-2029)

    Figure 46. Global Zika Virus Vaccines Revenue Market Share by Application (2018-2029)

    Figure 47. US & Canada Zika Virus Vaccines Sales Market Share by Type (2018-2029)

    Figure 48. US & Canada Zika Virus Vaccines Revenue Market Share by Type (2018-2029)

    Figure 49. US & Canada Zika Virus Vaccines Sales Market Share by Application (2018-2029)

    Figure 50. US & Canada Zika Virus Vaccines Revenue Market Share by Application (2018-2029)

    Figure 51. US & Canada Zika Virus Vaccines Revenue Share by Country (2018-2029)

    Figure 52. US & Canada Zika Virus Vaccines Sales Share by Country (2018-2029)

    Figure 53. U.S. Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 54. Canada Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 55. Europe Zika Virus Vaccines Sales Market Share by Type (2018-2029)

    Figure 56. Europe Zika Virus Vaccines Revenue Market Share by Type (2018-2029)

    Figure 57. Europe Zika Virus Vaccines Sales Market Share by Application (2018-2029)

    Figure 58. Europe Zika Virus Vaccines Revenue Market Share by Application (2018-2029)

    Figure 59. Europe Zika Virus Vaccines Revenue Share by Country (2018-2029)

    Figure 60. Europe Zika Virus Vaccines Sales Share by Country (2018-2029)

    Figure 61. Germany Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 62. France Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 63. U.K. Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 64. Italy Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 65. Russia Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 66. China Zika Virus Vaccines Sales Market Share by Type (2018-2029)

    Figure 67. China Zika Virus Vaccines Revenue Market Share by Type (2018-2029)

    Figure 68. China Zika Virus Vaccines Sales Market Share by Application (2018-2029)

    Figure 69. China Zika Virus Vaccines Revenue Market Share by Application (2018-2029)

    Figure 70. Asia Zika Virus Vaccines Sales Market Share by Type (2018-2029)

    Figure 71. Asia Zika Virus Vaccines Revenue Market Share by Type (2018-2029)

    Figure 72. Asia Zika Virus Vaccines Sales Market Share by Application (2018-2029)

    Figure 73. Asia Zika Virus Vaccines Revenue Market Share by Application (2018-2029)

    Figure 74. Asia Zika Virus Vaccines Revenue Share by Region (2018-2029)

    Figure 75. Asia Zika Virus Vaccines Sales Share by Region (2018-2029)

    Figure 76. Japan Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 77. South Korea Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 78. China Taiwan Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 79. Southeast Asia Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 80. India Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 81. Middle East, Africa and Latin America Zika Virus Vaccines Sales Market Share by Type (2018-2029)

    Figure 82. Middle East, Africa and Latin America Zika Virus Vaccines Revenue Market Share by Type (2018-2029)

    Figure 83. Middle East, Africa and Latin America Zika Virus Vaccines Sales Market Share by Application (2018-2029)

    Figure 84. Middle East, Africa and Latin America Zika Virus Vaccines Revenue Market Share by Application (2018-2029)

    Figure 85. Middle East, Africa and Latin America Zika Virus Vaccines Revenue Share by Country (2018-2029)

    Figure 86. Middle East, Africa and Latin America Zika Virus Vaccines Sales Share by Country (2018-2029)

    Figure 87. Brazil Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 88. Mexico Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 89. Turkey Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 90. Israel Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 91. GCC Countries Zika Virus Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 92. Zika Virus Vaccines Value Chain

    Figure 93. Zika Virus Vaccines Production Process

    Figure 94. Channels of Distribution

    Figure 95. Distributors Profiles

    Figure 96. Bottom-up and Top-down Approaches for This Report

    Figure 97. Data Triangulation

    Figure 98. Key Executives Interviewed